IBB icon

iShares Biotechnology ETF

419 hedge funds and large institutions have $6.6B invested in iShares Biotechnology ETF in 2015 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 134 increasing their positions, 150 reducing their positions, and 38 closing their positions.

Holders
419
Holders Change
+20
Holders Change %
+5.01%
% of All Funds
11.3%
Holding in Top 10
42
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+27.27%
% of All Funds
1.13%
New
65
Increased
134
Reduced
150
Closed
38
Calls
$665M
Puts
$1.9B
Net Calls
-$1.23B
Net Calls Change
-$621M
Name Market Value Shares Shares
Change
Shares
Change %
WP
451
WMS Partners
Maryland
-593 Closed
TNB
452
Thomasville National Bank
Georgia
-330 Closed
PCM
453
Parsons Capital Management
Rhode Island
-195 Closed
QAM
454
QCI Asset Management
New York
-76 Closed
PSI
455
Pinnacle Summer Investments
Virginia
-60 Closed
TFA
456
Transamerica Financial Advisors
Florida
-46 Closed
LWA
457
Lowe Wealth Advisors
Maryland
-3 Closed
NCM
458
Numina Capital Management
New York
SAM
459
Silphium Asset Management
United Kingdom
JG
460
Jefferies Group
New York
DCM
461
Driehaus Capital Management
Illinois
KCM
462
Kingdon Capital Management
New York
ID
463
Integral Derivatives
New York
MF
464
Magnetar Financial
Illinois
HT
465
HAP Trading
New York
CCM
466
Clovis Capital Management
New York
JGC
467
J. Goldman & Co
New York
Jennison Associates
468
Jennison Associates
New York
PC
469
Pomelo Capital
New York
FRM
470
Fore Research & Management
New York
AWM
471
Avior Wealth Management
Nebraska
LCM
472
Laurion Capital Management
New York
CA
473
Continental Advisors
Utah
MCM
474
Masters Capital Management
Georgia
Alyeska Investment Group
475
Alyeska Investment Group
Illinois